Antiglioma cytotoxic immune response.
Eggers
A E
AE
Miller
J I
JI
Parsa
A T
AT
D000119:Acetylmuramyl-Alanyl-Isoglutamine; D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000276:immunology* / Q000628:therapy*; D003602:Cytotoxicity, Immunologic; D004195:Disease Models, Animal; D005909:Glioblastoma / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D016233:Immunotherapy, Active; D051381:Rats; D014407:Tumor Cells, Cultured
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000119:Acetylmuramyl-Alanyl-Isoglutamine